4//SEC Filing
Anquillare Mark V 4
Accession 0001209191-21-070605
CIK 0001442145other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 5:20 PM ET
Size
19.3 KB
Accession
0001209191-21-070605
Insider Transaction Report
Form 4
Anquillare Mark V
SVP and CFO
Transactions
- Exercise/Conversion
Common Stock
2021-12-20$61.14/sh+20,480$1,252,147→ 41,982 total - Exercise/Conversion
Stock Option
2021-12-20−20,480→ 0 totalExercise: $61.14Exp: 2023-04-01→ Common Stock (20,480 underlying) - Sale
Common Stock
2021-12-20$216.02/sh−400$86,408→ 41,282 total - Sale
Common Stock
2021-12-20$217.98/sh−7,968$1,736,865→ 28,714 total - Sale
Common Stock
2021-12-20$214.71/sh−300$64,413→ 41,682 total - Sale
Common Stock
2021-12-20$216.82/sh−4,600$997,372→ 36,682 total - Sale
Common Stock
2021-12-20$219.18/sh−7,212$1,580,726→ 21,502 total
Holdings
- 57,000(indirect: By Trust)
Common Stock
- 9,027(indirect: By Trust)
Common Stock
Footnotes (9)
- [F1]These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $214.56 to $215.00, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (1).
- [F2]These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $215.80 to $216.43, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (2).
- [F3]These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $216.77 to $217.54, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (3).
- [F4]These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $217.56 to $218.46, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (4).
- [F5]These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $218.57 to $219.55, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (5).
- [F6]These shares of common stock are held by the Mark Anquillare Spousal Living Trust.
- [F7]These shares of common stock are held in a Revocable Trust.
- [F8]This stock option was granted under the Issuer's 2009 Equity Incentive Plan.
- [F9]Immediately.
Documents
Issuer
Verisk Analytics, Inc.
CIK 0001442145
Entity typeother
Related Parties
1- filerCIK 0001472710
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 5:20 PM ET
- Size
- 19.3 KB